Sunday, May 5, 2024
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Disclosures for additional planners can be found here.
Clinical Professor of Family Medicine
University of California, Irvine
Irvine, California
Professor and Associate Dean
Office of Academic Affairs
Department of Pharmacy Practice
Chapman University School of Pharmacy
Irvine, California
Professor of Pediatrics
Northwestern University Feinberg School of Medicine
Division of Pediatric Infectious Diseases
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois
George and Esther Gross Presidential Professor of Pediatrics and Medicine
University of Utah
Chief, Division of Pediatric Infectious Diseases
Salt Lake City, Utah
Professor, Division of Infectious Diseases
University of Louisville School of Medicine
Executive Director, Norton Infectious Diseases Institute
Norton Healthcare
Louisville, Kentucky
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
This activity is intended for primary care physicians, pediatricians, obstetricians, gynecologists, and emergency medicine physicians.
The goal of this activity is to improve clinicians’ understanding of data on antiviral therapy and prophylaxis for flu from infant to older adults, providing expert perspectives and interpretation for practical application.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Disclosures for additional planners can be found here.
Clinical Professor of Family Medicine
University of California, Irvine
Irvine, California
Professor and Associate Dean
Office of Academic Affairs
Department of Pharmacy Practice
Chapman University School of Pharmacy
Irvine, California
Professor of Pediatrics
Northwestern University Feinberg School of Medicine
Division of Pediatric Infectious Diseases
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois
George and Esther Gross Presidential Professor of Pediatrics and Medicine
University of Utah
Chief, Division of Pediatric Infectious Diseases
Salt Lake City, Utah
Professor, Division of Infectious Diseases
University of Louisville School of Medicine
Executive Director, Norton Infectious Diseases Institute
Norton Healthcare
Louisville, Kentucky
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Medscape, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.
Awarded 1.0 contact hour(s) of nursing continuing professional development for RNs and APNs; 1.0 contact hours are in the area of pharmacology.
Medscape designates this continuing education activity for 1.00 contact hour(s) (0.100 CEUs) (Universal Activity Number: JA0007105-0000-22-215-H01-P).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of
continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the
time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the
valid credit period that
is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in
your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as
the certificates from the
CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 7/13/2022
Valid for credit through: 7/13/2023, 11:59 PM EST
processing....
All sections of this activity are required for credit.
